title: 3D tissue-engineered bone marrow: what does this mean for the treatment of multiple myeloma?
authors.affiliation: Cancer Biology Division, Department of Radiation Oncology, Washington University in Saint Louis School of Medicine, St Louis, MO, USA.
authors.forename: Pilar
authors.initials: P
authors.lastname: de la Puente
authors.affiliation: Cancer Biology Division, Department of Radiation Oncology, Washington University in Saint Louis School of Medicine, St Louis, MO, USA.
authors.forename: Abdel Kareem
authors.initials: AK
authors.lastname: Azab
mesh_terms: D000818:Animals; D001853:Bone Marrow; D006801:Humans; D008954:Models, Biological; D009101:Multiple Myeloma / Q000473:pathology*; D017154:Stromal Cells; D023822:Tissue Engineering / Q000379:methods*
keywords: 3DTEBM; bone marrow; drug resistance; multiple myeloma; tissue-engineered cultures; tumor microenvironment